NO20055305D0 - Pyrrolopyridin-2-karboksylsyreamid-inhibitorer av glykogenfosforylase - Google Patents

Pyrrolopyridin-2-karboksylsyreamid-inhibitorer av glykogenfosforylase

Info

Publication number: NO20055305D0
Authority: NO; Norway
Prior art keywords: glycogen phosphorylase; pyrrolopyridine; carboxylic acid; acid amide; inhibitors
Prior art date: 2003-05-21

Application number

NO20055305A

Other languages

English (en)

Other versions

NO332265B1 (no

NO20055305L (no

Inventor

Karen Lesley Schofield

Stuart Edward Bradley

Thomas Martin Krulle

Peter John Murray

Martin James Procter

Robert John Rowley

Colin Peter Sambrook Smith

Gerard Hugh Thomas

Original Assignee

Prosidion Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-05-21

Filing date

2005-11-10

Publication date

2005-11-10

2005-11-10 Application filed by Prosidion Ltd filed Critical Prosidion Ltd

2005-11-10 Publication of NO20055305D0 publication Critical patent/NO20055305D0/no

2005-12-15 Publication of NO20055305L publication Critical patent/NO20055305L/no

2012-08-13 Publication of NO332265B1 publication Critical patent/NO332265B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Diabetes (AREA)
Hematology (AREA)
Cardiology (AREA)
Endocrinology (AREA)
Heart & Thoracic Surgery (AREA)
Obesity (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Emergency Medicine (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Pyrrole Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

NO20055305A 2003-05-21 2005-11-10 Pyrrolopyridin-2-karboksylsyreamidinhibitorer, fremstilling av og mellomprodukter ved fremstilling av slike, preparater og kombinasjoner omfattende slike, slike forbindelser og preparater som medikament samt slike forbindelser for behandling av sykdom NO332265B1 (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US47237503P	2003-05-21	2003-05-21
US55125604P	2004-03-08	2004-03-08
PCT/US2004/016243 WO2004104001A2 (en)	2003-05-21	2004-05-20	Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phoshorylase

Publications (3)

Publication Number	Publication Date
NO20055305D0 true NO20055305D0 (no)	2005-11-10
NO20055305L NO20055305L (no)	2005-12-15
NO332265B1 NO332265B1 (no)	2012-08-13

Family

ID=33479321

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20055305A NO332265B1 (no)	2003-05-21	2005-11-10	Pyrrolopyridin-2-karboksylsyreamidinhibitorer, fremstilling av og mellomprodukter ved fremstilling av slike, preparater og kombinasjoner omfattende slike, slike forbindelser og preparater som medikament samt slike forbindelser for behandling av sykdom

Country Status (16)

Country	Link
EP (1)	EP1636224B1 (no)
JP (2)	JP2006528702A (no)
KR (1)	KR101120935B1 (no)
AT (1)	ATE473974T1 (no)
AU (1)	AU2004240946B8 (no)
BR (1)	BRPI0410445B1 (no)
CA (1)	CA2525502C (no)
DE (1)	DE602004028122D1 (no)
EA (1)	EA009215B1 (no)
IL (1)	IL171851A (no)
MA (1)	MA27809A1 (no)
MX (1)	MXPA05012547A (no)
NO (1)	NO332265B1 (no)
NZ (1)	NZ543482A (no)
UA (1)	UA84146C2 (no)
WO (1)	WO2004104001A2 (no)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0205175D0 (en)	2002-03-06	2002-04-17	Astrazeneca Ab	Chemical compounds
GB0205166D0 (en)	2002-03-06	2002-04-17	Astrazeneca Ab	Chemical compounds
EP1685102A4 (en) *	2003-11-12	2008-08-20	Lg Life Sciences Ltd	melanocortin
EP1725555B1 (en) *	2004-03-08	2010-10-06	Prosidion Ltd.	Pyrrolopyridine-2-carboxylic acid hydrazides as inhibitors of glycogen phosphorylase
EP1732566A4 (en) *	2004-04-05	2010-01-13	Takeda Pharmaceutical	6-azaindole COMPOUND
DE102004054634A1 (de) *	2004-11-12	2006-05-18	Schwarz Pharma Ag	Azaindolcarboxamide
GB0425919D0 (en) *	2004-11-25	2004-12-29	Prosidion Ltd	Indole-2-carboxylic acid amides
WO2006059163A1 (en) *	2004-12-02	2006-06-08	Prosidion Limited	Treatment of diabetes with glycogen phosphorylase inhibitors
ATE424821T1 (de)	2004-12-02	2009-03-15	Prosidion Ltd	Pyrrolopyridin-2-karbonsäureamide
PT1819704E (pt)	2004-12-02	2008-10-06	Prosidion Ltd	Derivado amida de ácido pirrolopiridina-2-carboxílico útil como inibidor de glicogénio fosforilase
CA2626190A1 (en) *	2005-10-21	2007-05-03	Vertex Pharmaceuticals Incorporated	Derivatives for modulation of ion channels
US7351708B2 (en) *	2005-12-16	2008-04-01	Hoffmann-La Roche Inc.	Pyrrolo [2,3-b] pyridine derivatives
PE20080251A1 (es)	2006-05-04	2008-04-25	Boehringer Ingelheim Int	Usos de inhibidores de dpp iv
WO2008057933A2 (en)	2006-11-02	2008-05-15	Aestus Therapeutics, Inc.	Methods of treating neuropathic pain by modulation of glycogenolysis or glycolysis pathways
FR2911605B1 (fr)	2007-01-19	2009-04-17	Sanofi Aventis Sa	Derives de pyrrolopyridine-2-carbowamides, leur preparation et leur application en therapeutique
DE102007012284A1 (de)	2007-03-16	2008-09-18	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel
DE102007035333A1 (de)	2007-07-27	2009-01-29	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel
DE102007035334A1 (de)	2007-07-27	2009-01-29	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel
DE102007042154A1 (de)	2007-09-05	2009-03-12	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Arylsulfonylaminomethyphosphonsäure-Derivate, deren Herstellung und deren Verwendung als Arzneimittel
EP2340243B1 (en)	2008-10-17	2014-10-08	Boehringer Ingelheim International GmbH	Heteroaryl substituted indole compounds useful as mmp-13 inhibitors
UY32940A (es)	2009-10-27	2011-05-31	Bayer Cropscience Ag	Amidas sustituidas con halogenoalquilo como insecticidas y acaricidas
US8546416B2 (en)	2011-05-27	2013-10-01	Novartis Ag	3-spirocyclic piperidine derivatives as ghrelin receptor agonists
ES2642883T3 (es)	2011-05-31	2017-11-20	Theravance Biopharma R&D Ip, Llc	Inhibidores de neprilisina
WO2012166390A1 (en) *	2011-05-31	2012-12-06	Theravance, Inc.	Neprilysin inhibitors
ES2653215T3 (es)	2011-05-31	2018-02-06	Theravance Biopharma R&D Ip, Llc	Inhibidores de neprilisina
CN104718206B (zh)	2012-08-17	2017-03-08	拜尔农作物科学股份公司	作为杀虫剂和杀螨剂的氮杂吲哚甲酰胺和氮杂吲哚硫代甲酰胺
CN103626825B (zh) *	2013-09-30	2015-10-07	承德医学院	靶向肝脏的糖原磷酸化酶抑制剂胆酸类衍生物、其制备方法及医药用途
WO2015091645A1 (en)	2013-12-18	2015-06-25	Basf Se	Azole compounds carrying an imine-derived substituent
WO2021106988A1 (ja) *	2019-11-27	2021-06-03	杏林製薬株式会社	Ｇ９ａ阻害剤
CN116507627B (zh)	2020-11-02	2026-01-23	勃林格殷格翰国际有限公司	作为egfr抑制剂的经取代1h-吡唑并[4,3-c]吡啶及衍生物
IL305789A (en) *	2021-03-10	2023-11-01	Vincere Biosciences Inc	USP30 inhibitors and uses thereof
CN115894373B (zh) *	2022-10-27	2025-08-01	常州大学	N-取代苄基吡唑衍生物在作为β2肾上腺素受体调节剂、拮抗剂和激动剂的应用
CN115745891B (zh) *	2022-11-10	2025-08-01	常州大学	吡唑衍生物在作为β2-肾上腺素受体拮抗剂的应用
WO2023165168A1 (zh) *	2022-10-27	2023-09-07	常州大学	吡唑类衍生物作为β2肾上腺素受体别构调节剂,拮抗剂和激动剂的应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4619915A (en) *	1984-10-19	1986-10-28	Pfizer Inc.	Peptide-substituted heterocyclic immunostimulants
IL88619A0 (en) *	1987-12-15	1989-07-31	Pfizer	Non-peptidic renin inhibitors
WO1995033720A1 (en) *	1994-06-06	1995-12-14	The Green Cross Corporation	Novel fused-ring carboxylic acid compound or salt thereof, and medicinal use thereof
CA2342471C (en) *	1995-06-06	2002-10-29	Judith L. Treadway	Heterocyclecarbonylmethyl amine intermediates
MX9709874A (es) *	1995-06-06	1998-03-31	Pfizer	N-(INDOL-2-CARBONIL) beta-ALANILAMIDAS SUSTITUIDAS Y DERIVADOS COMO INHIBIDORES DE GLUCOGENO FOSFORILASA, USO DE LOS MISMOS Y COMPOSICIONES QUE LOS CONTIENEN.
KR100241643B1 (ko) *	1995-06-06	2000-03-02	디. 제이. 우드	당뇨병치료제인 치환된 N-(인돌-2-카르보닐)-β-알라님아미드 및 그의 유도체
US5952322A (en) *	1996-12-05	1999-09-14	Pfizer Inc.	Method of reducing tissue damage associated with non-cardiac ischemia using glycogen phosphorylase inhibitors
GB9902047D0 (en) *	1999-01-29	1999-03-17	Cerebrus Ltd	Chemical compounds XI
ES2211454T3 (es) *	1999-09-30	2004-07-16	Pfizer Products Inc.	Pirrolilamidas como inhibidores de la colageno fosforilasa.
GB0021831D0 (en) *	2000-09-06	2000-10-18	Astrazeneca Ab	Chemical compounds
GB0202015D0 (en) *	2002-01-29	2002-03-13	Hoffmann La Roche	Piperazine Derivatives
WO2004039807A1 (en) *	2002-10-30	2004-05-13	Merck Frosst Canada & Co.	Pyridopyrrolizine and pyridoindolizine derivatives

2004
- 2004-05-20 UA UAA200510756A patent/UA84146C2/ru unknown
- 2004-05-20 MX MXPA05012547A patent/MXPA05012547A/es active IP Right Grant
- 2004-05-20 NZ NZ543482A patent/NZ543482A/en not_active IP Right Cessation
- 2004-05-20 AT AT04753127T patent/ATE473974T1/de not_active IP Right Cessation
- 2004-05-20 EA EA200501645A patent/EA009215B1/ru not_active IP Right Cessation
- 2004-05-20 WO PCT/US2004/016243 patent/WO2004104001A2/en not_active Ceased
- 2004-05-20 BR BRPI0410445-5A patent/BRPI0410445B1/pt not_active IP Right Cessation
- 2004-05-20 JP JP2006533345A patent/JP2006528702A/ja not_active Withdrawn
- 2004-05-20 DE DE602004028122T patent/DE602004028122D1/de not_active Expired - Lifetime
- 2004-05-20 AU AU2004240946A patent/AU2004240946B8/en not_active Ceased
- 2004-05-20 CA CA2525502A patent/CA2525502C/en not_active Expired - Fee Related
- 2004-05-20 EP EP04753127A patent/EP1636224B1/en not_active Expired - Lifetime
2005
- 2005-11-09 IL IL171851A patent/IL171851A/en active IP Right Grant
- 2005-11-10 NO NO20055305A patent/NO332265B1/no not_active IP Right Cessation
- 2005-11-21 KR KR1020057022252A patent/KR101120935B1/ko not_active Expired - Fee Related
- 2005-11-21 MA MA28613A patent/MA27809A1/fr unknown
2011
- 2011-08-09 JP JP2011174163A patent/JP5669691B2/ja not_active Expired - Fee Related

Also Published As

Publication number	Publication date
MA27809A1 (fr)	2006-03-01
ATE473974T1 (de)	2010-07-15
AU2004240946B8 (en)	2012-01-12
MXPA05012547A (es)	2006-05-25
CA2525502A1 (en)	2004-12-02
WO2004104001A2 (en)	2004-12-02
NZ543482A (en)	2009-02-28
BRPI0410445A (pt)	2006-05-30
EP1636224A2 (en)	2006-03-22
JP2011252005A (ja)	2011-12-15
JP2006528702A (ja)	2006-12-21
DE602004028122D1 (de)	2010-08-26
NO332265B1 (no)	2012-08-13
UA84146C2 (ru)	2008-09-25
BRPI0410445B1 (pt)	2017-11-28
CA2525502C (en)	2012-12-18
EA009215B1 (ru)	2007-12-28
EP1636224B1 (en)	2010-07-14
AU2004240946B2 (en)	2011-09-08
AU2004240946A1 (en)	2004-12-02
WO2004104001A3 (en)	2005-03-03
IL171851A (en)	2011-08-31
KR101120935B1 (ko)	2012-03-05
JP5669691B2 (ja)	2015-02-12
KR20060069792A (ko)	2006-06-22
EA200501645A1 (ru)	2006-06-30
NO20055305L (no)	2005-12-15

Publication	Publication Date	Title
NO20055305D0 (no)	2005-11-10	Pyrrolopyridin-2-karboksylsyreamid-inhibitorer av glykogenfosforylase
EA200501095A1 (ru)	2006-04-28	Фенилацетамиды и их применение в качестве модуляторов глюкокиназы
JO2282B1 (en)	2005-09-12	Oxazole derivatives
EA200970161A1 (ru)	2009-06-30	Производные 1-(-d-гликопиранозил)-3-(4-циклопропилфенилметил)-4-галогеноиндола и их применение в качестве ингибиторов sglt
NO20081846L (no)	2008-06-04	Bifenylderivater og deres anvendelse ved behandling av hepatitt C
NO20051527L (no)	2005-03-22	3-(sulfonamidoetyl) -indol-derivater for anvendelse som glukocorticoid-mimetica ved behandling av inflammatoriske, allergiske og proliferative sykdommer.
DE60315336D1 (de)	2007-09-13	Pharmazeutische zusammensetzung und ihre verwendung als inhibitoren von der dipeptidyl peptidase iv (dpp-iv)
ATE384058T1 (de)	2008-02-15	Thiazolderivate
DE60316013D1 (de)	2007-10-11	Heteroaryl-pyrimidinderivate als jak-inhibitoren
DK1088824T3 (da)	2004-04-13	Bicykliske pyrrolylamider som glycogen phosphorylase inhibitorer
MXPA05008172A (es)	2005-10-05	Derivados de malonamida como inhibidores gamma-secretasa.
EA201001669A1 (ru)	2011-06-30	Замещенные пиримидин-5-карбоксамиды 281
NO20065260L (no)	2006-11-21	Tri(cyklo)substituerte amidforbindelser
NO20082496L (no)	2008-07-24	Pyrazinderivater
NO20082445L (no)	2008-09-03	Neuropeptid-2 reseptor-agonister
DE60003863D1 (de)	2003-08-21	Dioxocyclopentylhydroxamsäure
ATE483708T1 (de)	2010-10-15	Pyrrolopyridin-2-carbonsäurehydrazide als inhibitoren von glykogenphosphorylase
SE0402762D0 (sv)	2004-11-11	Indazole sulphonamide derivatives
ATE424821T1 (de)	2009-03-15	Pyrrolopyridin-2-karbonsäureamide
BR0212899A (pt)	2004-11-03	Compostos orgânicos
NO20052699L (no)	2005-06-06	4(fenylpiperazinyl-metyl)benzamid-derivater og deres anvendelse ved behandling av smerte og gastrointestinale lidelser.
ATE412636T1 (de)	2008-11-15	Piperazinylpyridinderivate als mittel gegen adipositas
WO2005085194A3 (en)	2006-01-05	Indole-2-carboxylic acid hydrazides as glycogen phosphorylase inhibitors
WO2006004903A3 (en)	2006-05-04	1,2-bis-(substituted-phenyl)-2-propen-1-ones and pharmaceutical compositions thereof
PL1806136T3 (pl)	2012-04-30	Kompozycja medyczna do zapobiegania przejściu na leczenie operacyjne łagodnego rozrostu gruczołu krokowego

Legal Events

Date	Code	Title	Description
2019-12-23	MM1K	Lapsed by not paying the annual fees